REPROCELL

reprocell-logo

ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clini... cal testing services that is required by hematopoietic stem cell transplantation and organ transplantation. On February 10, 2014, it established a Kanagawa-based wholly owned subsidiary. On June 30, 2014, it acquired 85.2% interests in Reinnervate Limited, a UK-based company. On July 1, 2014, it fully acquired Reinnervate Limited. In July, 2014, it acquired BioServe Biotechnologies, Ltd. On September 2, 2014, it completed the acquisition of BioServe Biotechnologies, Ltd.

#People #Financial #Website #More

REPROCELL

Social Links:

Industry:
Biotechnology Health Care Manufacturing Test And Measurement

Founded:
2003-01-01

Address:
Yokohama, Kanagawa, Japan

Country:
Japan

Website Url:
http://www.reprocell.com

Total Employee:
51+

Status:
Active

Contact:
(814) 547-5388

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Microsoft Exchange Online Office 365 Mail


Current Employees Featured

david-bunton_image

David Bunton
David Bunton Co-Founder&CEO @ ReproCELL
Co-Founder&CEO
2016-01-01

daisuke-usui_image

Daisuke Usui
Daisuke Usui Chief Operating Officer @ ReproCELL
Chief Operating Officer
2020-01-01

Founder


david-bunton_image

David Bunton

Stock Details


Company's stock symbol is TYO:4978

Acquisitions List

Date Company Article Price
2018-04-25 BioServe Biotechnologies (India) BioServe Biotechnologies (India) acquired by ReproCELL N/A
2015-11-24 Biopta Biopta acquired by ReproCELL N/A
2014-08-05 ReInnervate ReInnervate acquired by ReproCELL N/A

Investments List

Date Company Article Money raised
2019-04-25 Symic Biomedical ReproCELL investment in Series C - Symic Biomedical 11 M USD
2016-12-05 Kringle Pharma ReproCELL investment in Venture Round - Kringle Pharma 610 M JPY

Official Site Inspections

http://www.reprocell.com Semrush global rank: 1.46 M Semrush visits lastest month: 18.72 K

  • Host name: 109.108.148.102.srvlist.ukfast.net
  • IP address: 109.108.148.102
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "ReproCELL" on Search Engine